Humoral response against small heat shock proteins in Parkinson's disease.

INTRODUCTION:In the light of evidence for the increased heat shock proteins (HSP) expression in neurodegenerative disorders, the presence of the adaptive humoral response of the immune system can be expected. The aim of the study was to check whether Parkinson's disease (PD) has the ability to...

Full description

Bibliographic Details
Main Authors: Ewa Papuć, Ewa Kurys-Denis, Witold Krupski, Konrad Rejdak
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4309535?pdf=render
id doaj-cd1059ffd7934acd8b153887c695a428
record_format Article
spelling doaj-cd1059ffd7934acd8b153887c695a4282020-11-25T01:33:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01101e011548010.1371/journal.pone.0115480Humoral response against small heat shock proteins in Parkinson's disease.Ewa PapućEwa Kurys-DenisWitold KrupskiKonrad RejdakINTRODUCTION:In the light of evidence for the increased heat shock proteins (HSP) expression in neurodegenerative disorders, the presence of the adaptive humoral response of the immune system can be expected. The aim of the study was to check whether Parkinson's disease (PD) has the ability to elicit immune response against small heat shock proteins. METHODS:IgG and IgM autoantibodies against alpha B-crystallin were assessed in 26 PD patients 26 healthy subjects. For the assessment of anti-HSP IgG autoantibodies serum samples from 31 parkinsonian patients and 31 healthy control subjects were collected. Serum samples from PD patients and healthy control subjects were collected twice, at baseline and after mean of 13 months follow up. RESULTS:Both IgM and IgG autoantibodies against alpha ß-crystallin in PD patients were significantly higher compared to healthy controls (p<0.05). We also found statistically significant increase in antibodies titers against alpha ß-crystallin over the time of 13 months, both for IgG (p = 0.021) and for IgM (p<0.0001). Additionally, PD patients presented higher levels of anti-HSP IgG autoantibodies than healthy controls (p = 0.02). CONCLUSIONS:Increase of IgG and IgM autoantibodies against alpha B-crystallin in PD patients over time may suggest their involvement in the disease pathogenesis and progression. Further studies are required to confirm the role of this antibody as a biomarker of the disease progression.http://europepmc.org/articles/PMC4309535?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Ewa Papuć
Ewa Kurys-Denis
Witold Krupski
Konrad Rejdak
spellingShingle Ewa Papuć
Ewa Kurys-Denis
Witold Krupski
Konrad Rejdak
Humoral response against small heat shock proteins in Parkinson's disease.
PLoS ONE
author_facet Ewa Papuć
Ewa Kurys-Denis
Witold Krupski
Konrad Rejdak
author_sort Ewa Papuć
title Humoral response against small heat shock proteins in Parkinson's disease.
title_short Humoral response against small heat shock proteins in Parkinson's disease.
title_full Humoral response against small heat shock proteins in Parkinson's disease.
title_fullStr Humoral response against small heat shock proteins in Parkinson's disease.
title_full_unstemmed Humoral response against small heat shock proteins in Parkinson's disease.
title_sort humoral response against small heat shock proteins in parkinson's disease.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description INTRODUCTION:In the light of evidence for the increased heat shock proteins (HSP) expression in neurodegenerative disorders, the presence of the adaptive humoral response of the immune system can be expected. The aim of the study was to check whether Parkinson's disease (PD) has the ability to elicit immune response against small heat shock proteins. METHODS:IgG and IgM autoantibodies against alpha B-crystallin were assessed in 26 PD patients 26 healthy subjects. For the assessment of anti-HSP IgG autoantibodies serum samples from 31 parkinsonian patients and 31 healthy control subjects were collected. Serum samples from PD patients and healthy control subjects were collected twice, at baseline and after mean of 13 months follow up. RESULTS:Both IgM and IgG autoantibodies against alpha ß-crystallin in PD patients were significantly higher compared to healthy controls (p<0.05). We also found statistically significant increase in antibodies titers against alpha ß-crystallin over the time of 13 months, both for IgG (p = 0.021) and for IgM (p<0.0001). Additionally, PD patients presented higher levels of anti-HSP IgG autoantibodies than healthy controls (p = 0.02). CONCLUSIONS:Increase of IgG and IgM autoantibodies against alpha B-crystallin in PD patients over time may suggest their involvement in the disease pathogenesis and progression. Further studies are required to confirm the role of this antibody as a biomarker of the disease progression.
url http://europepmc.org/articles/PMC4309535?pdf=render
work_keys_str_mv AT ewapapuc humoralresponseagainstsmallheatshockproteinsinparkinsonsdisease
AT ewakurysdenis humoralresponseagainstsmallheatshockproteinsinparkinsonsdisease
AT witoldkrupski humoralresponseagainstsmallheatshockproteinsinparkinsonsdisease
AT konradrejdak humoralresponseagainstsmallheatshockproteinsinparkinsonsdisease
_version_ 1725078094115504128